Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107104 · ClinicalTrials.gov registry record
Triton Fundus Autofluorescence and Fluorescein Angiography
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 47
- Enrollment target
NCT03107104: Completed study, sponsored by Topcon Medical Systems.
NCT03107104 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03107104 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
Compare the image quality of the fundus autofluorescence and fluorescein angiography
Interventions
- DEVICE Topcon DRI OCT Triton (plus)
- DEVICE TRC-50DX retinal camera
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-03-30 |
| Est. Completion | 2017-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03107104
The ClinicalTrials.gov registry entry for NCT03107104 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topcon Medical Systems, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topcon DRI OCT Triton (plus) is the first listed.
NCT03107104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03107104 about?
NCT03107104 is a clinical study titled "Triton Fundus Autofluorescence and Fluorescein Angiography". Compare the image quality of the fundus autofluorescence and fluorescein angiography
What is the current status of trial NCT03107104?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2017-03-30. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT03107104?
The interventions under investigation include: Topcon DRI OCT Triton (plus) (DEVICE), TRC-50DX retinal camera (DEVICE).
Who is sponsoring clinical trial NCT03107104?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.